Merger Rumors for Japan's Drug Firms
Executive Summary
Shionoghi and Sumitomo Pharmaceuticals are both facing big cuts in revenues as American and European partners take back marketing rights to major products. Sumitomo Bank, a major shareholder and debtholder in both, is likely to try to put the two companies together.